Idexx Laboratories | IDXX - Equity Capital And Reserves


Idexx Laboratories reported $1.61B in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Abbott USD 52.13B 1.3B Dec/2025
Accuray USD 61.87M 19.3M Sep/2025
Align Technology USD 3.96B 44.68M Sep/2025
AngioDynamics USD 185.87M 898K Feb/2025
Dentsply International USD 1.48B 482M Sep/2025
Dexcom USD 2.75B 19.9M Dec/2025
Edwards Lifesciences USD 10.2B 340.3M Sep/2025
Fujifilm JPY 3.72T 230.16B Dec/2025
Globus Medical USD 4.57B 174.42M Dec/2025
Henry Schein USD 3.24B 116M Dec/2025
Hologic USD 5.25B 197.2M Dec/2025
Idexx Laboratories USD 1.61B 44.2M Dec/2025
Inogen USD 197.18M 2.32M Sep/2025
Insulet USD 1.52B 131.1M Dec/2025
Integra LifeSciences USD 1.04B 5.89M Dec/2025
Intuitive Surgical USD 17.82B 894.3M Dec/2025
Masimo USD 810M 232.8M Sep/2025
Neogen USD 2.1B 14.16M Sep/2025
Orthofix International USD 442.49M 15.86M Sep/2025
Phibro Animal Health USD 332.36M 20.68M Dec/2025
ResMed USD 6.32B 199.61M Dec/2025
Roche Holding CHF 33.8B 758M Dec/2025
Steris USD 7.15B 145.4M Dec/2025
Tandem Diabetes Care USD 155.17M 22.2M Dec/2025
Teleflex USD 3.12B 697.09M Dec/2025
Thermo Fisher Scientific USD 53.54B 2.38B Dec/2025
Zoetis USD 3.33B 2.07B Dec/2025